- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02011308
KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)
November 13, 2017 updated by: Hannu Koistinen, University of Helsinki
The Effect of KTP Green Light Prostatectomy (120W) Compared With TUR-P When Treating Benign Prostatic Hyperplasia (BPH), a Prospective Randomized Study
The purpose of this study is to compare safety and efficacy of Green Light PVP (Photoselective Vaporisation of the Prostate) compared to TUR-P.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
217
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Helsinki, Finland, 00350
- Helsinki University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Men undergoing surgery for BPH
Exclusion Criteria:
- Previous prostate surgery
- Carcinoma of the prostate
- Neurogenic bladder
- Bladder carcinoma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Green Light Laser
|
Laser vs TURP
Laser vs TURP
|
Active Comparator: TURP
Transurethral Resection of the Prostate
|
Laser vs TURP
Laser vs TURP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IPSS (International Prostate Symptom Score)
Time Frame: 12 months
|
symptom
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
DAN-PSS (Danish Prostate Symptom Score)
Time Frame: 3, 6 and 12 months
|
symptom
|
3, 6 and 12 months
|
Maximum flow rate (Qmax)
Time Frame: 3, 6 and 12 months
|
3, 6 and 12 months
|
|
Residual urine
Time Frame: 3, 6 and 12 months
|
3, 6 and 12 months
|
|
Length of catheterization
Time Frame: Postoperative recovery
|
Postoperative recovery
|
|
Length of hospital stay
Time Frame: Postoperative recovery
|
Postoperative recovery
|
|
Perioperative bleeding
Time Frame: Time of operation
|
Time of operation
|
|
IIEF (International Index of Erectile Function questionnaire)
Time Frame: 12 months
|
Erectile Dysfunction
|
12 months
|
TRUS (transrectal ultrasound)
Time Frame: 12 months
|
Measurement of prostate size
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Hannu T Koistinen, M.D., Helsinki University Central Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
February 21, 2012
First Submitted That Met QC Criteria
December 10, 2013
First Posted (Estimate)
December 13, 2013
Study Record Updates
Last Update Posted (Actual)
November 14, 2017
Last Update Submitted That Met QC Criteria
November 13, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 34/13/03/02/08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on BPH (Benign Prostatic Hyperplasia)
-
Catholic University of the Sacred HeartCompletedBenign Prostatic Hyperplasia (BPH) | Benign Prostatic Enlargement (BPE)Italy
-
Medi-Tate Ltd.CompletedBenign Prostatic Hyperplasia (BPH)Spain, Belgium, Italy, Switzerland, United Kingdom
-
GemVax & KaelCompletedBenign Prostatic Hyperplasia (BPH)Korea, Republic of
-
University of Kansas Medical CenterEnrolling by invitationBenign Prostatic Hyperplasia | BPHUnited States
-
Brooklyn Urology Research GroupAmerican Medical Systems; Richard Wolf Medical Instruments Corporation (RWMIC)CompletedBenign Prostatic Hyperplasia (BPH)United States
-
Daniel Stephan EngelerCompletedBenign Prostatic Hyperplasia (BPH)Switzerland
-
HistoSonics, Inc.WithdrawnBenign Prostatic Hyperplasia (BPH)
-
Watson PharmaceuticalsCompletedBenign Prostatic Hyperplasia (BPH)United States
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Lawson Health Research InstituteGyrus ACMI, Inc.CompletedBenign Prostatic Hyperplasia | BPHCanada
Clinical Trials on Green light Laser
-
University of HelsinkiCompletedBPH (Benign Prostatic Hyperplasia)Finland
-
University Hospital, Strasbourg, FranceRecruiting
-
University of ArizonaBanner Alzheimer's InstituteNot yet recruitingFibromyalgiaUnited States
-
Selçuk UniversityCompletedPost Operative Pain | Anxiety, DentalTurkey
-
New York Institute of TechnologyRecruitingPain, Chronic | Ehlers-Danlos SyndromeUnited States
-
University of California, San DiegoNational Institute of Mental Health (NIMH)Completed
-
AurolabRaja Ramanna Centre for Advanced Technology (RRCAT)Completed
-
Boston Children's HospitalRecruitingEpilepsy | Epilepsy IntractableUnited States
-
Kaohsiung Medical UniversityCompletedSleep Disorder | Dementia | Mild Cognitive Impairment | PhototherapyTaiwan
-
Icahn School of Medicine at Mount SinaiRecruitingAlzheimer Disease | Mild Cognitive ImpairmentUnited States